Adverse side-effects and lack of scientific validation of some chemotherapeutic agents prevent the use of many traditional medicines claimed to have anti-cancer effects. Ethanolic extract of Conium maculatum has long been used in traditional and alternative systems of medicine including homeopathy for the treatment of glandular enlargements, cancerous tumours or hard lumps of testicles, prostate, ovaries, breasts and/ or uterus, particularly in the breast. However, if and how it acts still remains scientifically unknown. This study aims to test if Conium extract (CE), used as mother tincture of Conium in homeopathy, has demonstrable anti-cancer potentials without having much cytotoxicity in normal cells. Cytotoxicity of the drug was tested by conducting MTT assay on both normal (peripheral blood mononuclear cells) and HeLa cells. We also evaluated DNA fragmentation and DNA damage by DAPI and diphenylamine assay. The LDH activity assay was done to evaluate the percentages of apoptosis and necrosis. ROS accumulation also was evaluated to pin-point the actual events of apoptosis. Administration of drug clearly demonstrated its anti-cancer potentials as evidenced by the DNA damage analysis. The ROS activity also increased in case of the CE treated cells. LDH data revealed that the mode of cell death was mainly apoptotic and not necrotic. CE appears to induce apoptosis of cancer cells through ROS mediated pathway, and has negligible cytotoxicity against normal cells.
INTRODUCTION
The cervix carcinoma is responsible for most number of deaths by cancer in female population (Ahemedin et al., 2011) . Chemo-prevention against the cervical cancer is not very effective and except for surgical intervention before the metastasis starts, there is hardly any remedial measure that can prove successful to control this cancerous growth (Fulda and Debatin, 2007) ; therefore, there is an urgent need of remedial drug development strategy to combat this dreadful situation.
Reactive oxygen species (ROS) plays a central part of metabolism in cells, which regulates different cellular functions like cell proliferation, differentiation, self-renewal and removal of unwanted cells through apoptosis and necrosis (Fruehauf and Meyskens, 2007) . The normal human cells possess certain level of ROS activity, but the cancer cells contain a higher level of ROS activity due to its higher metabolic rates. If the ROS level could be increased to a further extent that is up to threshold level the cells could undergo apoptosis or necrosis (Lowe and Lin, 2000) . This could be a way to control the immortality of cancer cells by drug without damaging the normal cells.
The accumulation of ROS and DNA damage are two inter-dependent events that take place in unison. In other words, the increased level of ROS beyond the threshold level causes increased DNA damage of the cells (Lopez-Lazaro, 2007) . If the drug used for the therapy can have the ability to further increase the ROS accumulation, there will automatically be a chance of increase in cellular DNA damage.
The condensation and fragmentation of DNA are major hallmarks of apoptosis. When a drug induces DNA fragmentation, it can have a potent anti-cancer role as well. The changes in cellular morphology (membrane distortion, blebbing) also are the major hallmark of apoptosis (Green, 2011) . So, the drug which can induce DNA fragmentation, and cell blebbing, could be considered one with an anti-cancer potential and that can be used to combat cancer.
Homeopathy is a system of medicine founded on a definite law 'Similia Similibus Curantur' which means 'like cures like'. The word Homeopathy is a Greek derivation where 'homeos' means 'similar and pathos means 'suffering'. So Homeopathy may be defined as the therapeutic method of symptom-similarity and ancient ayurvedic texts have on occasions mentioned this law. According to this system, the choice of the medicine is fundamentally based on the principle that the medicine must have the capability of producing most similar symptoms of the disease to be cured in healthy persons (Boericke, 2002; Khuda-Bukhsh, 2003) . Therefore, to ameliorate the sufferings of the patients, the use of many types of complementary and alternative medicine (CAM) as supportive cancer care is becoming more popular day by day, and that includes the use of homeopathy. Therefore, the validation of homeopathic remedies by conducting scientifically acceptable protocols is extremely important.
Conium maculatum is derived from the toxic plant hemlock which is native to Europe, particularly Britain, North America, Africa, Chile and certain regions in Asia (http://www.herbs2000.com/homeopathy/conium.htm). Conium is prepared from leaves, roots and flowering stems of hemlock plant by using ethanol as the extracting solvent. In homeopathy, this medicine is generally used to treat glandular enlargements, for instance, cancerous tumours or hard lumps of testicles, prostate, ovaries, breasts and/ or uterus, but particularly in glandular enlargement in the breast region. In addition, conium is also prescribed by homeopaths to cure nervous disorders. The homeopathic remedy conium is effective in curing a number of health problems suffered by women. This medicine is particularly useful for aged women who are in their climacteric age (Boericke, 2004) . In Conium, eight piperidinic alkaloids have been identified in this species. Two of them, gamma-coniceine and coniine are generally the most abundant and produce plant's acute and chronic toxicity. Conium contains the pyridine alkaloids like coniine, N-methylconiine, conhydrine, pseudoconhydrine and gamma-coniceine, which are the precursors of the other hemlock alkaloids (Schep et al., 2009 ); these toxic materials may induce the ROS accumulation in the cancer cells, even in lower doses.
In this context, we have tried to evaluate the anticancer activity of conium on Hela cells, for the first time. We deployed several methods like cell viability assay, LDH (Lactate dehydrogenase) enzyme activity, intercellular ROS (reactive oxygen species) activity, morphological study and fluorescence microscopic study of DNA damage to ascertain the effects, if any, of different doses of conium on HeLa cells. As a further confirmatory method to detect apoptosis, DNA fragmentation assay was used. In this study, to provide information on whether the cell death occurs due to apoptosis or necrosis, we also conducted LDH assay.
MATERALS AND METHODS

Cell culture
The Hela cells (NCCS, India) were maintained in the humidified incubator (Thermo, USA) with ambient oxygen and 5% carbon dioxide level. Cells were cultured in DMEM (Dulbecco's Modified Eagle Medium) (Gibco, USA) supplemented with 10% heat inactivated FBS (fetal bovine serum) (Gibco, NZ) and 1% PSN (penicillinstreptomycin-neomycin antibiotic) (HiMedia, India). Cells were harvested with 1 Trypsin-EDTA (Gibco, Canada) in phosphate buffer saline (SRL, India) and plated at required cell numbers and allowed to adhere for 24 h before treatment. The cells were plated at a density of 2  10 3 /well on 96 well tissue culture plates (Tarson, India) for viability experiments, and for 2  10 6 DNA fragmentation assay on 70 mm culture dish (Tarson, India) or 2  10 4 on 6 well plates (Tarson, India) for morphology and fluorescence study, respectively.
MTT/Cell viability assay
In vitro growth inhibition effect of CE on HeLa cells was determined by measuring 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, USA) dye absorbance of living cells. The HeLa and PBMC (peripheral blood mononuclear cell) were dispensed in 96 well flat bottom microtiter plates at a density of 2 × 10 3 cells per well. Exponentially growing cells were exposed to CE at different concentrations for 24 and 48 h. MTT solution was then added to each well and incubated for 4 h at 37  C. To achieve solubilization of the formazan crystals formed in viable cells, media was discarded and 100 µl acidic isopropanol (Merck, India) was added to each well and optical density (O.D.) was measured at 595 nm in an ELISA reader (Thermo scientific, USA). The absorbance correlates linearly to the number of living cells in culture (Chakraborty et al., 2012 LDH assay LDH activity was assessed using a standardized kinetic determination kit (Recon, India). LDH activity was measured in both floating dead cells and adherent viable cells for control and drug treated cells. The floating cells were collected from culture medium by centrifugation (500 g) at 4ºC for 2 min, and the LDH content from the pellets was used as an index of apoptotic cell death (LDHp). The LDH released in the culture supernatant (designated as extracellular LDH (LDHe)) was used as an index of necrotic death, and the LDH present in the adherent viable cells was designated as intracellular LDH (LDHi) (Mandal et al., 2010) . The percentages of apoptotic and necrotic cell deaths were calculated as follows: 
Fluorescence microscopic study of DAPI staining
In order to detect whether CE induced nuclear chromatin condensation, staining with DAPI was performed. Control and treated cells were stained with 10 µg/ml of DAPI (4',6' Diamidino-2-phenylindole dihydrochloride) (Sigma, USA), visualized under fluorescence microscope and photograph taken with 20 magnification and photographs were taken using Moticam and analysed by Motic Image software.
Fluorescence microscopic study of DCHFDA staining
In order to detect whether CE induced ROS accumulation, staining with DCHFDA (2',7'-Dichloro Dihydro Fluorescein Diacetate) was performed. Control and treated cells were stained with 10 µg/ml of DCHFDA (Sigma, USA), visualized under fluorescence microscope and photograph taken with 10 magnification and photographs were taken using Moticam and analysed by Motic Image software.
Quantification of DNA fragmentation 1 ml of cell suspension (2  10 6 ) was harvested at 200g. The supernatant (S) and pellet (B) both was dissolved in Tris-buffer-Triton-X (TTE) (SRL, India) solution with vigorous vortexing. The suspension (B) was then centrifuged at 20,000 g for 10 min at 4  C (REMI, India). The supernatant was transferred to new tube (T). 25% trichloro acetic acid (TCA) (Loba Chemi, India) was mixed vigorously with S, B and T. The precipitation was allowed for overnight at 4  C. After removing the supernatant, DNA was hydrolysed by adding 160 µl of 5% TCA and heating 15 min at 90  C in a heating block. Then to each tube, freshly prepared DPA (diphenylamine) (SRL (India) solution was added and the mixture vortexed well and kept for colour development for overnight. 200 µl coloured solution was transferred to 96 well plate avoiding the dark particles (Ioannou and Chen, 1996) . The OD was taken at 600nm in ELISA reader using a blank (160 µl of 5% TCA and 320 µl DPA alone). (ii) DAPI staining: DAPI can bind to the fragmented DNA. The more amount of fragmentation gave more fluorescence intensity. The fragmentation was observed to be in the highest range at the highest drug dose. (iii) DCHFDA staining: more amounts of ROS were generated in the higher drug dose treated cells than the control set.
Percentage of fragmentation = (S + T) (S + T + B)
× 100
Statistical Analysis
Statistical analysis was performed by one-way ANOVA with LSD post-hoc tests, using SPSS.14 software to identify if the differences were significant among the mean-values of different groups. Results were expressed as Mean ± SE (Standard Error). p < 0.05 was considered as significant.
RESULTS
Evaluation of cell viability
Results of MTT assay revealed that the cell viability was gradually decreased from minimal drug concentration to the higher ones at both 24 and 48 h. The percentages of viability were: 96.21 ± 1.98 at the dose 0.07 µg/µl to 36.48 ± 0.99 at the dose 0.84 µg/µl of drug at 24 h; for the 48 h fixation time point, the percentages of cell viability were: 95.11 ± 2.19 at 0.07 µg/µl to 36.93 ± 0.27 at 0.84 µg/µl of drug. The 50% cell death occurred at 0.72 ± 0.01 µg/µl at 24 h and 0.57 ± 0.01 at 48 h of drug employment (Fig. 1i) . The cell cytotoxicity on normal PBMC was also measured in the mentioned dose of CE which showed 85 ± 1.15 and 78.33 ± 2.4 at highest drug dose for 24 and 48 h, respectively (Fig. 1ii) to PBMC.
Determination of apoptosis and necrosis percentages
The percentage value of cell death by apoptosis and necrosis was determined by LDH activity assay. After the drug treatment the apoptotic percentages were increased from 15.04 ± 1.82 (C) to 19.12 ± 6.34, 28.92 ± 0.68 and 46.96 ± 2.47 in case of D1, D2 and D3 doses, respectively. The necrotic percentages were relatively lower in the drug treated cells than in the control set, and they were 1.62 ± 0.28, 0.35 ± 0.35, 2.15 ± 0.54 and 2.26 ± 1.49 for C, D1, D2 and D3, respectively (Fig.  2) .
Microscopic studies Cellular morphology
The morphological distortion and the cell blebbing were observed in the drug treated cells. The cellular distortion was found to be most frequent in case of higher doses (Fig. 3i) .
DAPI staining
The fragmented DNA was observed in the drug treated cells than in the control ones. The DNA breakage mostly occurred in case of the highest drug dose (Fig. 3ii) used.
DCHFDA staining
The amount of ROS accumulation was higher in case of the higher doses. The blue colour intensity was gradually increased in the higher drug doses. The D3 had the most ROS accumulation and has the highest amount of florescence (Fig.  3iii) .
Analysis of DNA fragmentation assay
The amount of fragmented DNA was increased with the drug treatment. The control set contained 19.34 ± 0.57% of fragmented DNA and upon the drug treatment, the fragmented percentages were 23.49 ± 0.98, 38.84 ± 0.98 and 54.27 ± 1.74 for D1, D2 and D3, respectively (Fig. 4) .
DISCUSSION
Cervix cancer is a major health problem in females and chemotherapy or radio therapy is often found to be ineffective after a certain period of treatment, because the cancer cells become unresponsive to the therapy (Massague, 2004) . Additionally, unwanted side-effects and/or the toxicity of the conventional (orthodox) drugs in normal tissues and normal cells often make the problem complicated. We observed that CE reduced the viability of the cancerous cells but not of the normal cells and induced apoptotic condition to the cancer infected cells. Initiation of necrotic cell death is another problem with the conventional anti-cancer drugs due to their higher cytotoxic nature, so in the drug designing, this factor should be taken care (Lemasters et al., 1998) of. A potent complete anti-cancer drug can only initiate apoptosis to the cancer cells but not necrosis (Kim et al., 2003) . The CE used in this study initiated apoptosis to the HeLa cells with a negligible necrotic cell death. The LDH activity assay also supported this nature of the drug.
The initiation of cellular morphology change and DNA fragmentation are two major hallmarks of cancer (Green, 2011) . The apoptotic cells' chromosome gets condensed and fragmented. The drug induced both the cellular phenomena in the HeLa cells.
ROS is the central component and can control different cellular behaviours. The cancer cells possess a higher level of ROS due to their high metabolic activity. But, if a drug can increase ROS level of cells to a further extent, raising it beyond the threshold level, then they can push the cells more strongly to the apoptosis (Lopez-Lazaro, 2007) . In this study, the ROS level was found to be increased by the drug induction. The accumulation ROS has the capacity to induce DNA damage of the cells, and this DNA damage can lead them to death. The DCHFDA and DAPI staining also supports the cellular ROS accumulation and DNA damage upon drug treatment in the HeLa cells.
In conclusion, we can state that, the CE has the ability to accumulate reactive oxygen species in the cancer cells and thus leads the cells to apoptotic pathway through the cytotoxic effects, but it has less cytotoxic effect to the normal cells.
Thus, the critical analysis of overall data would convincingly demonstrate the anti-cancer potentials of CE and the information would be important in designing specific drug for chemo-therapeutics, apart from validating its use in homeopathy and CAM practices as an anti-cancer drug.
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